Nephron Pharmaceutical Corporation is recalling 5,040 vials of Ketorolac Tromethamine Injection (60 mg/2 mL). The recall is due to manufacturing deviations that may have led to potential cross-contamination of the medication. No incidents or injuries have been reported to date regarding this issue.
Cross-contamination in an injectable medication can introduce unintended substances into the drug, which may cause adverse reactions or reduce the effectiveness of the treatment.
Recall Number: D-1354-2022; Distributed Nationwide in the USA.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.